Strand AI
Strand AI
Strand AI uses foundation models to predict missing patient data, helping pharma teams select better trial candidates and bring effective drugs to market faster
- Use Cases
- Not listed yet
- Pricing
- Custom
- Platforms
- Not listed yet
Overview
Unlock the Full Potential of Your Clinical Trials with Predictive Multimodal Patient Data
Strand AI helps life sciences teams overcome the limitations of incomplete patient data, a major contributor to the 90% failure rate of clinical trials, by predicting missing biological modalities from existing data, enabling more accurate patient selection and biomarker discovery.
Details
Key Features
- Rescue incomplete cohorts by predicting missing modalities, reducing the need for additional invasive and expensive assays
- Generate high-quality multimodal patient data, including gene expression, proteomics, and spatial transcriptomics, from routinely collected samples
- Unlock rare disease cohorts by filling in missing modalities, enabling more effective model training and biomarker discovery
- Impute unmeasured biomarkers across entire cohorts, surfacing predictive signatures without the need for re-acquisition
Best For
- Life sciences teams running clinical trials and seeking to improve patient selection and biomarker discovery
- Researchers working with rare disease cohorts and requiring more comprehensive and accurate data
- Biopharmaceutical companies aiming to reduce the cost and time associated with clinical trials and improve drug development outcomes
Read full editorial notes
Key Features
Rescue incomplete cohorts by predicting missing modalities, reducing the need for additional invasive and expensive assays
Generate high-quality multimodal patient data, including gene expression, proteomics, and spatial transcriptomics, from routinely collected samples
Unlock rare disease cohorts by filling in missing modalities, enabling more effective model training and biomarker discovery
Impute unmeasured biomarkers across entire cohorts, surfacing predictive signatures without the need for re-acquisition
Streamline clinical trial workflows by skipping the expensive and time-consuming process of acquiring every modality for every patient
Ideal For
Life sciences teams running clinical trials and seeking to improve patient selection and biomarker discovery
Researchers working with rare disease cohorts and requiring more comprehensive and accurate data
Biopharmaceutical companies aiming to reduce the cost and time associated with clinical trials and improve drug development outcomes
Alternatives
A shortlist of related products to compare before you leave the page.
Signal Lens Pro
Unlock actionable insights with Signal Lens Pro. Advanced data analytics platform for mode...
AI
Subscription, Freemium
Data Analysts, AI Researchers
By providing a comprehensive view of your business performance, Signal Lens Pro helps you overcome the challenge of making informed decisions in a rap...
- Real-time analytics that empower you to respond swiftly to market shifts, reducing reaction time by up to 50% and increasing agility.
- Advanced data visualization tools that simplify complex data sets, making it easier for stakeholders at all levels to understand key metrics and trends.
- AI-driven predictive analytics that forecast future outcomes, allowing you to proactively adjust strategies and minimize potential pitfalls.
F
Finto
AI that automates 75% of accounting work
AI
Custom
Legacy accounting tools still rely on manual processes that slow down operations and require large teams or outsourcing. Finto changes that by embeddi...
RunLLM
An AI engineer that learns your stack
Productivity
Custom
🤖 Accurate technical answers
Launched
Ideal for
Data Analysts
Ownership
If this is your product, contact us and we can help transfer it to you.
